118 related articles for article (PubMed ID: 7522235)
1. Relative topography of biologically active domains of human vitronectin. Evidence from monoclonal antibody epitope and denaturation studies.
Morris CA; Underwood PA; Bean PA; Sheehan M; Charlesworth JA
J Biol Chem; 1994 Sep; 269(38):23845-52. PubMed ID: 7522235
[TBL] [Abstract][Full Text] [Related]
2. Complement inhibition by human vitronectin involves non-heparin binding domains.
Sheehan M; Morris CA; Pussell BA; Charlesworth JA
Clin Exp Immunol; 1995 Jul; 101(1):136-41. PubMed ID: 7542572
[TBL] [Abstract][Full Text] [Related]
3. Immunochemical analysis of monoclonal antibodies to human erythropoietin.
Wognum AW; Lansdorp PM; Krystal G
Exp Hematol; 1990 Mar; 18(3):228-33. PubMed ID: 1689248
[TBL] [Abstract][Full Text] [Related]
4. Antibodies with specificity for native and denatured forms of ovalbumin differ in reactivity between enzyme-linked immunosorbent assays.
Holm BE; Bergmann AC; Hansen PR; Koch C; Houen G; Trier NH
APMIS; 2015 Feb; 123(2):136-45. PubMed ID: 25470666
[TBL] [Abstract][Full Text] [Related]
5. Immunochemical mapping of alpha-2 interferon.
Lydon NB; Favre C; Bove S; Neyret O; Benureau S; Levine AM; Seelig GF; Nagabhushan TL; Trotta PP
Biochemistry; 1985 Jul; 24(15):4131-41. PubMed ID: 2413884
[TBL] [Abstract][Full Text] [Related]
6. Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation.
Kost C; Stüber W; Ehrlich HJ; Pannekoek H; Preissner KT
J Biol Chem; 1992 Jun; 267(17):12098-105. PubMed ID: 1376317
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans.
Moore JP; Ho DD
J Virol; 1993 Feb; 67(2):863-75. PubMed ID: 7678308
[TBL] [Abstract][Full Text] [Related]
8. Human epidermal growth factor (EGF) receptor sequence recognized by EGF competitive monoclonal antibodies. Evidence for the localization of the EGF-binding site.
Wu DG; Wang LH; Sato GH; West KA; Harris WR; Crabb JW; Sato JD
J Biol Chem; 1989 Oct; 264(29):17469-75. PubMed ID: 2477372
[TBL] [Abstract][Full Text] [Related]
9. Immunochemistry of human Lp[a]: characterization of monoclonal antibodies that cross-react strongly with plasminogen.
Lafferty MA; Salamon AM; Usher DC
J Lipid Res; 1991 Feb; 32(2):277-92. PubMed ID: 1712375
[TBL] [Abstract][Full Text] [Related]
10. The binding of monoclonal and polyclonal antibodies to the Ca2(+)-ATPase of sarcoplasmic reticulum: effects on interactions between ATPase molecules.
Molnar E; Seidler NW; Jona I; Martonosi AN
Biochim Biophys Acta; 1990 Apr; 1023(2):147-67. PubMed ID: 1691656
[TBL] [Abstract][Full Text] [Related]
11. Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop.
Stigbrand T; Andrés C; Bellanger L; Bishr Omary M; Bodenmüller H; Bonfrer H; Brundell J; Einarsson R; Erlandsson A; Johansson A; Leca JF; Levi M; Meier T; Nap M; Nustad K; Seguin P; Sjödin A; Sundström B; van Dalen A; Wiebelhaus E; Wiklund B; Arlestig L; Hilgers J
Tumour Biol; 1998; 19(2):132-52. PubMed ID: 9486565
[TBL] [Abstract][Full Text] [Related]
12. Epitope mapping and tight-binding inhibition with monoclonal antibodies directed against Escherichia coli glucosamine 6-phosphate synthase.
Cochet O; Badet-Denisot MA; Teillaud JL; Badet B
Arch Biochem Biophys; 1995 Dec; 324(2):391-400. PubMed ID: 8554332
[TBL] [Abstract][Full Text] [Related]
13. Epitope mapping for four monoclonal antibodies against human plasminogen activator inhibitor type-1: implications for antibody-mediated PAI-1-neutralization and vitronectin-binding.
Wind T; Jensen MA; Andreasen PA
Eur J Biochem; 2001 Feb; 268(4):1095-106. PubMed ID: 11179976
[TBL] [Abstract][Full Text] [Related]
14. Repeated helical epitopes of defined amino acid sequence in human type III collagen identified by monoclonal antibodies.
Hori H; Keene DR; Sakai LY; Wirtz MK; Bächinger HP; Godfrey M; Hollister DW
Mol Immunol; 1992 Jun; 29(6):759-70. PubMed ID: 1376414
[TBL] [Abstract][Full Text] [Related]
15. Binding specificity of monoclonal antibodies towards fragments of human growth hormone produced by plasmin digestion.
Wallis M; Daniels M
FEBS Lett; 1983 Aug; 159(1-2):241-5. PubMed ID: 6192016
[TBL] [Abstract][Full Text] [Related]
16. Anti-idiotypic antibodies against an antibody to the platelet glycoprotein (GP) IIb-IIIa complex mimic GP IIb-IIIa by recognizing fibrinogen.
Abrams CS; Ruggeri ZM; Taub R; Hoxie JA; Nagaswami C; Weisel JW; Shattil SJ
J Biol Chem; 1992 Feb; 267(4):2775-85. PubMed ID: 1370832
[TBL] [Abstract][Full Text] [Related]
17. Functional topography of myelin-associated glycoprotein. II. Mapping of domains on molecular fragments.
Meyer-Franke A; Tropak MB; Roder JC; Fischer P; Beyreuther K; Probstmeier R; Schachner M
J Neurosci Res; 1995 Jun; 41(3):311-23. PubMed ID: 7563224
[TBL] [Abstract][Full Text] [Related]
18. Further characterization of the thrombasthenia-related idiotype OG. Antiidiotype defines a novel epitope(s) shared by fibrinogen B beta chain, vitronectin, and von Willebrand factor and required for binding to beta 3.
Gruel Y; Brojer E; Nugent DJ; Kunicki TJ
J Exp Med; 1994 Dec; 180(6):2259-67. PubMed ID: 7525851
[TBL] [Abstract][Full Text] [Related]
19. The immunodominant region on human thyroid peroxidase recognized by autoantibodies does not contain the monoclonal antibody 47/c21 linear epitope.
Chazenbalk GD; Costante G; Portolano S; McLachlan SM; Rapoport B
J Clin Endocrinol Metab; 1993 Dec; 77(6):1715-8. PubMed ID: 7505290
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of tick-borne encephalitis virus glycoprotein fragments: epitope-specific analysis of the antibody response.
Heinz FX; Tuma W; Guirakhoo F; Berger R; Kunz C
J Gen Virol; 1984 Nov; 65 ( Pt 11)():1921-9. PubMed ID: 6209362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
